I don’t know what other data they have, but Mindstate’s Phase 1 trial size was only 47, and how effective it was wasn’t actually documented in the article (other than vague “it was safe and well-tolerated” language). It’s obviously not poison, but whether it actually treated anything is still an open question, and how effective it will be for people in general is another; they’re aiming for the FDA to approve the drug on it’s own, and just producing a neuroplastic mental state may not be enough without guided therapy.

I sincerely hope for a drug that’s effective at treating various mental disorders, but the funding on this is practically the “who’s who” of Conservative/billionaire ghouls:

Founded in 2021 and backed by Y Combinator and the founders of OpenAI, Neuralink, Instacart, Coinbase, and Twitch, Mindstate has built a set of AI models that connect biochemical data from different psychactive drugs to more than 70,000 “trip reports” compiled from a variety of sources—from official clinical trial datasets and drug forums to social media, Reddit, and even the dark web.

Behold the new faces of Big Pharma. These aren’t the sort to do things for the benefit of humanity. It might turn out that this is exactly what is promised on the tin, but I will be surprised if this is not gated by a steep price tag.